Lanthio Pharma discovers and develops Lanthiopeptides, a new class of peptides with high target selectivity and improved “drug-like” properties. Lanthio pharma was acquired by Morphosys in 2015.
Member count: 11-50
Total raised: $6.208207M
Founded date: 2010
Investors 1
| Date | Name | Website |
| 03.08.2021 | BioGenerat... | biogenerat... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 28.11.2012 | Series A | $6.208207M | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 28.11.2012 | Lanthio Ph... | Lanthio Pharma B.V., a Groning... | funding N... | - | finsmes.co... |